Argenx Se (ARGX) Enterprise Value Growth (1y) (2016 - 2025)
Argenx Se (ARGX) Enterprise Value Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.41% |
| Jun 30, 2025 | -266.42% |
| Dec 31, 2024 | -6.26% |
| Jun 30, 2024 | 55,532.62% |
| Dec 31, 2023 | -45.03% |
| Jun 30, 2023 | 23.12% |
| Dec 31, 2022 | 6.17% |
| Jun 30, 2022 | 4.89% |
| Dec 31, 2021 | -20.46% |
| Jun 30, 2021 | -28.28% |
| Dec 31, 2020 | -31.19% |
| Jun 30, 2020 | -100.64% |
| Dec 31, 2019 | -129.46% |
| Jun 30, 2019 | -162.37% |
| Dec 31, 2018 | -52.12% |
| Jun 30, 2018 | -112.07% |
| Dec 31, 2017 | -305.60% |
| Dec 31, 2016 | -125.11% |